These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Therapy of tuberculosis].
    Author: Eier A, Grass S.
    Journal: Wien Med Wochenschr; 1994; 144(8-9):186-8. PubMed ID: 7941607.
    Abstract:
    The treatment of tuberculosis consists of a combination of at least 3 antituberculosis drugs to prevent occurrence of resistance. Each drug is discussed in detail. Different therapy regimens are described taking into consideration ethnic origin, compliance and underlying diseases of the patients. Standard therapy consists of a short course therapy including rifampicin, isoniazid and pyrazinamide for 6 months. Duration of therapy is extended in immunocompromised patients and in particular organ manifestations of the disease (i.e. meningitis etc.). Intermittent therapy improves compliance of the patients. Four-drug-regimens are recommended until the results of drug susceptibility tests are available in patients originating of countries with high prevalence of resistant strains.
    [Abstract] [Full Text] [Related] [New Search]